Fx/CNPq (465259/2014-6) and FAPESP (2013/07600-3). Molecular docking calculations were performed and included in the
manuscript as requested by one of the Reviewers.
References
1
2
.
.
Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res. 2010;85(2):328-345. doi:10.1016/j.antiviral.2009.10.008
Mayer S V., Tesh RB, Vasilakis N. The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya
and zika fevers. Acta Trop. 2017;166:155-163. doi:10.1016/j.actatropica.2016.11.020
3.
4.
5.
6.
Sukhralia S, Verma M, Gopirajan S, et al. From dengue to Zika: the wide spread of mosquito-borne arboviruses. Eur J Clin Microbiol
Infect Dis. 2019;38(1):3-14. doi:10.1007/s10096-018-3375-7
Callender DM. Management and control of yellow fever virus: Brazilian outbreak January-April, 2018. Glob Public Health.
2
019;14(3):445-455. doi:10.1080/17441692.2018.1512144
Ventura C V, Maia M, Bravo-Filho V, Góis AL, Belfort R. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet.
016;387(10015):228. doi:10.1016/S0140-6736(16)00006-4
2
Henriques-Souza A, de Azevedo Marques ET, Antunes de Brito CA, et al. Guillain–Barré Syndrome, Acute Disseminated
Encephalomyelitis and Encephalitis Associated with Zika Virus Infection in Brazil: Detection of Viral RNA and Isolation of Virus during
Late Infection. Am J Trop Med Hyg. 2017;97(5):1405-1409. doi:10.4269/ajtmh.17-0106
7.
van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP. Long-term sequelae of chikungunya virus disease: A systematic review.
Travel Med Infect Dis. 2017;15:8-22. doi:10.1016/j.tmaid.2017.01.004
8
9
1
.
.
0.
Brizzi K. Neurologic Manifestation of Chikungunya Virus. Curr Infect Dis Rep. 2017;19(2):6. doi:10.1007/s11908-017-0561-1
Platt DJ, Miner JJ. Consequences of congenital Zika virus infection. Curr Opin Virol. 2017;27:1-7. doi:10.1016/j.coviro.2017.09.005
Meneses JDA, Ishigami AC, de Mello LM, et al. Lessons Learned at the Epicenter of Brazil’s Congenital Zika Epidemic: Evidence From
8
7 Confirmed Cases. Clin Infect Dis. 2017;64(10):1302-1308. doi:10.1093/cid/cix166
PAHO/WHO. Zika cases and congenital syndrome associated with Zika virus reported by countries and territories in the Americas,
015-2018. Cumulative cases. https://www.paho.org/hq/index.php?option=com_docman&task=doc_download&gid=43297&lang=en.
11.
2
Published 2018. Accessed June 17, 2019.
12.
13.
14.
15.
16.
17.
18.
World Health Organization. Situation Report: Zika Virus, Microcephaly, Guillain-Barré Syndrome, 10 March 2017.; 2017.
http://apps.who.int/iris/bitstream/10665/254714/1/zikasitrep10Mar17-eng.pdf?ua=1.
Liu-Helmersson J, Stenlund H, Wilder-Smith A, Rocklöv J. Vectorial Capacity of Aedes aegypti : Effects of Temperature and
Implications for Global Dengue Epidemic Potential. Moreira LA, ed. PLoS One. 2014;9(3):e89783. doi:10.1371/journal.pone.0089783
Goyal M, Chauhan A, Goyal V, Jaiswal N, Singh S, Singh M. Recent development in the strategies projected for chikungunya vaccine
in humans. Drug Des Devel Ther. 2018;12:4195-4206. doi:10.2147/DDDT.S181574
das Neves Almeida R, Racine T, Magalhães K, Kobinger G. Zika Virus Vaccines: Challenges and Perspectives. Vaccines.
2018;6(3):62. doi:10.3390/vaccines6030062
Viana-Medeiros PF, Bellinato DF, Martins AJ, Valle D. Insecticide resistance, associated mechanisms and fitness aspects in two
Brazilian Stegomyia aegypti (= Aedes aegypti ) populations. Med Vet Entomol. 2017;31(4):340-350. doi:10.1111/mve.12241
Bellinato DF, Viana-Medeiros PF, Araújo SC, Martins AJ, Lima JBP, Valle D. Resistance Status to the Insecticides Temephos,
Deltamethrin, and Diflubenzuron in Brazilian Aedes aegypti Populations. Biomed Res Int. 2016;2016:1-12. doi:10.1155/2016/8603263
de Araújo AP, Paiva MHS, Cabral AM, et al. Screening Aedes aegypti (Diptera: Culicidae) Populations From Pernambuco, Brazil for
Resistance to Temephos, Diflubenzuron, and Cypermethrin and Characterization of Potential Resistance Mechanisms. J Insect Sci.
2019;19(3)(16):1-15. doi:10.1093/jisesa/iez054
19.
20.
21.
22.
Nkya TE, Akhouayri I, Kisinza W, David J-P. Impact of environment on mosquito response to pyrethroid insecticides: Facts, evidences
and prospects. Insect Biochem Mol Biol. 2013;43(4):407-416. doi:10.1016/j.ibmb.2012.10.006
Liu N. Insecticide Resistance in Mosquitoes: Impact, Mechanisms, and Research Directions. Annu Rev Entomol. 2015;60(1):537-559.
doi:10.1146/annurev-ento-010814-020828
Sokhna C, Ndiath MO, Rogier C. The changes in mosquito vector behaviour and the emerging resistance to insecticides will challenge
the decline of malaria. Clin Microbiol Infect. 2013;19(10):902-907. doi:10.1111/1469-0691.12314
Kasai S, Komagata O, Itokawa K, et al. Mechanisms of Pyrethroid Resistance in the Dengue Mosquito Vector, Aedes aegypti : Target
Site Insensitivity, Penetration, and Metabolism. Kittayapong P, ed. PLoS Negl Trop Dis. 2014;8(6):e2948.
doi:10.1371/journal.pntd.0002948
2
3.
4.
Li J, Li G. Transamination of 3-hydroxykynurenine to produce xanthurenic acid: a major branch pathway of tryptophan metabolism in
the mosquito, Aedes aegypti , during larval development. Insect Biochem Mol Biol. 1997;27(10):859-867. doi:10.1016/S0965-
1748(97)00068-4
2
Li J, Beerntsen BT, James AA. Oxidation of 3-hydroxykynurenine to produce xanthommatin for eye pigmentation: a major branch
pathway of tryptophan catabolism during pupal development in the Yellow Fever Mosquito, Aedes aegypti . Insect Biochem Mol Biol.
1
999;29(4):329-338. doi:10.1016/S0965-1748(99)00007-7
Chen Y, Guillemin GJ. Kynurenine Pathway Metabolites in Humans: Disease and Healthy States. Int J Tryptophan Res. 2009;2(1):1-
9. doi:10.4137/IJTR.S2097
Schwarcz R, Stone TW. The kynurenine pathway and the brain: Challenges, controversies and promises. Neuropharmacology.
017;112(August):237-247. doi:10.1016/j.neuropharm.2016.08.003
25.
26.
27.
28.
29.
1
2
Vazquez S, Garner B, Sheil MM, Truscott RJW. Characterisation of the major autoxidation products of 3- hydroxykynurenine under
physiological conditions. Free Radic Res. 2000;32(1):11-23. doi:10.1080/10715760000300021
Giles GI, Collins CA, Stone TW, Jacob C. Electrochemical and in vitro evaluation of the redox-properties of kynurenine species.
Biochem Biophys Res Commun. 2003;300(3):719-724. doi:10.1016/S0006-291X(02)02917-0
Sathyasaikumar KV, Tararina M, Wu H-Q, et al. Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain:
Neurochemical
doi:10.1016/j.neuroscience.2017.10.006
Han Q, Fang J, Li J. 3-Hydroxykynurenine Transaminase Identity with Alanine Glyoxylate Transaminase. J Biol Chem.
002;277(18):15781-15787. doi:10.1074/jbc.M201202200
Han Q, Kim SR, Ding H, Li J. Evolution of two alanine glyoxylate aminotransferases in mosquito. Biochem J. 2006;397(3):473-481.
doi:10.1042/BJ20060469
Characterization
and
Physiological
Effects.
Neuroscience.
2017;367(3):85-97.
30.
31.
32.
2
Han Q, Li J. Comparative characterization of Aedes 3-hydroxykynurenine transaminase/alanine glyoxylate transaminase and
16